BIOMAT Database Logo BIOMAT Database Logo

Intraarterial infusion of cisplatin with and without preoperative concurrent radiation for urinary bladder cancer: a preliminary report. 1995

Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Department of Radiology, Oita Medical University, Japan.

We evaluated the clinical efficacy of treating urinary bladder cancer by intraarterial infusion of cisplatin using an implanted reservoir with and without preoperative concurrent radiation. No previous reports have compared the results obtained by these two methods of treatment. Twenty-three patients with bladder cancer were treated by intraarterial infusion of cisplatin using an implanted reservoir with (n = 13) and without (n = 10) concurrent radiation. The cisplatin plus radiation group received intraarterial cisplatin at a total dose of 200-400 mg and concurrent radiation to a total dose to 30 Gy. The cisplatin group received intraarterial cisplatin at a total dose of 100-600 mg. In the cisplatin plus radiation group, the overall tumor response rate was 92%. Seven of 13 (53%) patients obtained complete response (CR), and the 2-year actuarial survival rate was 92%. Only one of the seven complete responders has had a local recurrence. In the cisplatin group, the overall tumor response rate was 90%. Four of 10 (40%) patients obtained CR, and median survival was 8 months. Three of the four complete responders have had local recurrence. There was no significant difference between these two groups in the frequency of side effects. Concurrent radiation therapy with intraarterial cisplatin resulted in a very low rate of recurrence of bladder cancer compared with intraarterial cisplatin therapy alone. This method was useful for urinary bladder cancer and may become the treatment of choice for this type of cancer.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012074 Remission Induction Therapeutic act or process that initiates a response to a complete or partial remission level. Induction of Remission,Induction, Remission,Inductions, Remission,Remission Inductions
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
February 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer.
March 1995, International journal of urology : official journal of the Japanese Urological Association,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Combined intraarterial cisplatin infusion and radiation therapy for invasive bladder cancer.
May 1995, International journal of urology : official journal of the Japanese Urological Association,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report.
November 1982, The Journal of urology,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Radiation therapy and concurrent daily intra-arterial infusion of low-dose cisplatin following alteration of pelvic blood flow for invasive bladder cancer: a preliminary report.
January 1998, Anticancer research,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Preliminary results of concurrent cisplatin and radiation therapy in locally advanced bladder cancer.
October 1992, British journal of urology,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
[Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer].
October 1991, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Neoadjuvant intraarterial infusion chemotherapy with a combination of mitomycin-C, vincristine, and cisplatin for locally advanced cervical cancer: a preliminary report.
December 1992, Gynecologic oncology,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Preliminary results of bladder preservation by concurrent intraarterial chemotherapy and radiotherapy for muscle-invasive bladder cancer.
May 1998, International journal of urology : official journal of the Japanese Urological Association,
Y Monzen, and H Mori, and S Matsumoto, and H Takaki, and S Yoshida, and M Wakisaka, and S Ueda, and H Mizoguchi, and J Ogata, and Y Kato
Intraarterial low-dose cisplatin via an indwelling port and concurrent radiotherapy for invasive bladder cancer.
March 2001, Journal of vascular and interventional radiology : JVIR,
Copied contents to your clipboard!